Table 1.
Author | ctDNA Diagnostic |
Target | Sensitivity | Specificity |
---|---|---|---|---|
Ahn et al. [8] | qPCR | HPV16 E6 and E7 | 67% (n = 93) | 100% (n = 9) |
Siravegna et al. [28] | ddPCR | HPV E7 (multiple strains) | 98% (n = 70) | 99% (n = 70) |
Mattox et al. [22] | ddPCR | HPV16 E6 | 8% (n = 66) | |
qPCR | HPV16 E6 | 2% | ||
NGS | HPV16 E6 | 75% | ||
Veyer et al. [29] | ddPCR | HPV E6 | 71% (n = 66) | |
Tanaka et al. [30] | ddPCR | HPV E6 and E7 | 67% (n = 93) | 97% (n = 32) |
Hanna et al. [31] | ddPCR | HPV E7 | 76% (n = 21) | |
Chera et al. [32] | ddPCR | HPV16 E7 and additional strains | 89% (n = 103) | 97% (n = 115) |
Cao et al. [33] | Conventional PCR | HPV E6 and E7 | 65% (n = 40) | |
Wang et al. [34] | ddPCR | HPV16 and 18 E7 | 91% (n = 22) | |
Rettig et al. [25] | ddPCR | Unspecified HPV sequences and mutated oncogenes | 43% (n = 7) | 100% (n = 100) |
Leung et al. [35] | HPVseq | E6 and E7 and full-length HPV strains including 16 and 18 | 100% (n = 17) | |
Tewari et al. [36] | Conventional PCR | HPV DNA | 100% (n = 407) |